Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J Clin Oncol. 2004 Jan 01; 22(1):115-9.